World of Showjumping

This week

Coming weeks

CSI5* LGCT Stockholm

CSI5*/CSI2* St.Tropez-Grimaud

CSIO5* Sopot

CSIO3* EEF RQ Bojourishte

CSI3* Lexington

CSI2* Bonheiden

CSI2* Fontainebleau

CSI2* Peelbergen
The Netherlands

CSI2* Barcelona

CSI2* Vidauban

CSI2* San Giovanni in ...

CSI2* San Remo

CSI2* Traverse City

CSI2*-W Moscow

CSI2*-W Olomouc
Czech Republic

One participating horse in Opglabbeek returns positive samples for EHV-1

Thursday, 06 May 2021

The FEI has announced that samples taken from a horse which was participating for consecutive weeks in Opglabbeek, Belgium – and which therefore was subject to mandatory PCR testing under the FEI Return To Competition measures – have returned positive for EHV-1. 

An update from the FEI on May 5th in regard to the positive samples reads: 

“The horse, which has no clinical signs but has been put into isolation, had tested negative for EHV-1 prior to travel to Opglabbeek. The athlete’s other four horses have also been isolated and the boxes vacated by all five horses have been thoroughly cleaned, disinfected and sealed in line with the FEI Return To Competition measures. None of the five horses has shown any clinical signs. All five horses have been retested and are being closely monitored by the Veterinary Delegate for any clinical signs. No other horses were stabled within six metres of this athlete’s horses during last week’s CSI at the venue. 

The Opglabbeek Organisers, who have fully adhered to the FEI Return To Competition protocols with regard to this horse and its in-contacts, have also informed all athletes with horses entered to participate at the venue. In addition, the FEI has contacted Organisers and Veterinary Delegates of events in Belgium and the Netherlands in the next two weeks, advising them that there is no requirement for them to take any measures additional to the FEI Return to Competition protocols.”

This photo has been added to your cart !

Your shopping cart »
This website is using cookies for statistics, site optimization and retargeting purposes. You consent to our cookies if you continue to use this website. Read more here.